Examining the Feasibility of Implementing a Hypertension Storytelling Intervention Among African Americans

NCT ID: NCT07071077

Last Updated: 2025-07-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-29

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess if storytelling is an effective approach for promoting lifestyle and behavioral change among individuals managing hypertension and to determine if storytelling interventions can help to reduce blood pressure and improve medication adherence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

Group Type NO_INTERVENTION

No interventions assigned to this group

Storytelling (Web-based Storytelling)

Group Type EXPERIMENTAL

Web-Based Storytelling Intervention

Intervention Type BEHAVIORAL

The Web-based storytelling group will access stories and educational materials on the study website.

Storytelling Plus (Group-based Storytelling)

Group Type EXPERIMENTAL

Group-Based Storytelling Plus Intervention

Intervention Type BEHAVIORAL

The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Web-Based Storytelling Intervention

The Web-based storytelling group will access stories and educational materials on the study website.

Intervention Type BEHAVIORAL

Group-Based Storytelling Plus Intervention

The storytelling plus group will watch the stories in a group setting, share their experiences and have educational sessions led by a health coach.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* African American/Black
* Diagnosed with Hypertension
* Prescribed medication for hypertension

Exclusion Criteria

* Cognitive limitations that limit the ability to provide informed consent
* Pregnancy
* Unable to speak or read English
* Planning to relocate during the study period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

University of Delaware

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yendelela Cuffee

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Delaware

Newark, Delaware, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Yendelela Cuffee

Role: primary

302-831-1302

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5K01HL166372-02

Identifier Type: NIH

Identifier Source: secondary_id

View Link

2034724-5

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrition Education
NCT00005728 COMPLETED
The Health for Hearts United Collaborative
NCT05259150 ENROLLING_BY_INVITATION NA
Twitter and Diabetes
NCT02806700 COMPLETED NA